First Wave BioPharma Inc, based in Boca Raton, Florida, is a clinical-stage biopharmaceutical company focusing on developing non-systemic therapies for gastrointestinal diseases, including adrulipase and niclosamide. Since its IPO in 2016, the company employs 10 people and conducts Phase 2 clinical trials for treatments targeting cystic fibrosis, chronic pancreatitis, and coronavirus-related GI infections.
ENTO filed a patent for "stable lipase formulations and methods thereof" on Thu, December 15, 2022. The patent was officially published on Thu, June 22, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
